Literature Reviews

The article by Paul McCarthy in the May 30, 1994, issue of The Scientist [page 1] on peer review struck a responsive note. I, too, have come to distrust journal reviewers and National Institutes of Health pink sheets despite good fortune with publications and grants over many years. Responsibility and devotion are far less than they were one and two generations ago, perhaps a mirror of our end-of- century society. But I have a solu

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article by Paul McCarthy in the May 30, 1994, issue of The Scientist [page 1] on peer review struck a responsive note. I, too, have come to distrust journal reviewers and National Institutes of Health pink sheets despite good fortune with publications and grants over many years. Responsibility and devotion are far less than they were one and two generations ago, perhaps a mirror of our end-of- century society.

But I have a solution, at least for journal reviews. I do favor signed reviews, but this will probably never fly. But why shouldn't reviewers be required to document their comments, citing appropriate literature? Can't these godlike, nameless shadows be brought into scientific focus?

THOMAS H. MAREN
University of Florida
College of Medicine
P.O. Box 100267
Gainesville, Fla. 32620-0267

(The Scientist, Vol:8, #16, pg.13, August 22, 1994) (Copyright, The Scientist, Inc.)

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Thomas Maren

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio